A detailed history of Simplex Trading, LLC transactions in Galecto, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 647 shares of GLTO stock, worth $7,569. This represents 0.0% of its overall portfolio holdings.

Number of Shares
647
Previous 547 18.28%
Holding current value
$7,569
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$0.47 - $0.76 $47 - $76
100 Added 18.28%
647 $0
Q1 2024

Apr 25, 2024

BUY
$0.6 - $0.89 $280 - $416
468 Added 592.41%
547 $0
Q4 2023

Feb 02, 2024

SELL
$0.52 - $0.78 $7,096 - $10,645
-13,648 Reduced 99.42%
79 $0
Q3 2023

Nov 01, 2023

BUY
$0.56 - $3.17 $1,303 - $7,379
2,328 Added 20.42%
13,727 $9,000
Q2 2023

Aug 04, 2023

BUY
$1.68 - $2.84 $18,646 - $31,521
11,099 Added 3699.67%
11,399 $28,000
Q1 2023

Apr 27, 2023

BUY
$1.21 - $2.86 $363 - $858
300 New
300 $0
Q3 2022

Nov 04, 2022

BUY
$1.59 - $60.0 $14,505 - $547,380
9,123 Added 1881.03%
9,608 $18,000
Q2 2022

Aug 03, 2022

BUY
$1.22 - $2.74 $501 - $1,126
411 Added 555.41%
485 $0
Q1 2022

May 02, 2022

SELL
$1.72 - $3.31 $825 - $1,588
-480 Reduced 86.64%
74 $0
Q4 2021

Feb 23, 2022

BUY
$2.3 - $3.58 $1,274 - $1,983
554 New
554 $1,000

Others Institutions Holding GLTO

About Galecto, Inc.


  • Ticker GLTO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,395,700
  • Market Cap $297M
  • Description
  • Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clini...
More about GLTO
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.